ArticleWorld journal of gastroenterology2010
Endoscopic features and prognoses of mantle cell lymphoma with gastrointestinal involvement.
Article in World journal of gastroenterology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 40 citations in OpenAlex.
- Esophageal involvement of mantle cell lymphoma presenting with multiple lymphomatous polyposis: A single-center study.World journal of gastrointestinal oncology · 2025Article
- Review of lymphoma in the duodenum: An update of diagnosis and management.World journal of gastroenterology · 2023Review
- Mantle Cell Lymphoma with Multiple Lymphomatous Polyposis.Internal medicine (Tokyo, Japan) · 2022Article
- Mantle Cell Lymphoma Presenting as Acute Abdominal Syndrome: A Rare Case Report and Literature Review.Healthcare (Basel, Switzerland) · 2021Article
- Peritonitis due to colon mantle cell lymphoma.Journal of surgical case reports · 2021Article
- 18F-FDG PET/CT Cannot Substitute Endoscopy in the Staging of Gastrointestinal Involvement in Mantle Cell Lymphoma. A Retrospective Multi-Center Cohort Analysis.Journal of personalized medicine · 2021Article
- A Unique Case of Mantle Cell Lymphoma Masquerading as a Cecal Mass.Case reports in gastrointestinal medicine · 2021Article
- Gastrointestinal Mantle Cell Lymphoma with Varied Findings.Journal of gastrointestinal cancer · 2020Article
- Noninfectious Cloudy Peritoneal Effluent in a Peritoneal Dialysis Patient with Mantle Cell Lymphoma.Cureus · 2018Article
- Mantle Cell Lymphoma with a Single Protruding Lesion as the Cause of Intussusception.Internal medicine (Tokyo, Japan) · 2018Article
- Multiple Lymphomatous Polyposis of the Intestine with Ileocecal Intussusception Due to Mantle Cell Lymphoma: A Case Report of a 34-Year-Old Man.The American journal of case reports · 2018Review
- Gastrointestinal involvement by mantle cell lymphoma identified by biopsy performed during endoscopy: A case report.Medicine · 2018Article
- Gastrointestinal mantle cell lymphoma with isolated mass and multiple lymphomatous polyposis: report of two cases.Clinical journal of gastroenterology · 2017Article
- Rare gastrointestinal lymphomas: The endoscopic investigation.World journal of gastrointestinal endoscopy · 2015Review
- Endoscopic ultrasound-guided biliary drainage: a review.Current treatment options in gastroenterology · 2015Article
- ¹⁸F-FDG PET/CT imaging for a gastrointestinal mantle cell lymphoma with multiple lymphomatous polyposis.World journal of gastroenterology · 2014Article
- Mantle cell lymphoma mimicking rectal carcinoma.Case reports in hematology · 2014Article
- Successful treatment with tandem consolidation using 90yttrium-ibritumomab tiuxetan (Zevalin) and high-dose therapy with autologous PBSCT in a patient with relapsed mantle cell lymphoma presenting as multiple lymphomatous polyposis.Bone marrow transplantation · 2012Article
- Blastic Mantle Cell Lymphoma of the Gastroesophageal Junction: A Unique Presentation and Literature Review.Case reports in gastroenterologyArticle
- Blastoid Mantle Cell Lymphoma Presenting as an Isolated Cecal Mass.Journal of investigative medicine high impact case reportsArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimTo evaluate the endoscopic manifestations and prognoses of gastrointestinal (GI) mantle cell lymphoma (MCL).
methodsA database search at the Department of Pathology of Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences revealed 57 MCL patients with GI involvement. Clinical records were available for 35 of the 57 patients from 21 institutions, and those 35 patients were enrolled in this study. We summarized the gross types of endoscopic features, event-free survival (EFS), and overall survival (OS) of those patients.
resultsOf the 35 patients, GI involvement in the esophagus, stomach, and duodenum was found in 2 (5.7%), 26 (74.3%), and 12 (34.3%) patients, respectively. Twenty-one of the 35 patients underwent colonoscopy; among them, GI involvement in the ileum, cecum, colon, and rectum was found in 10 (47.6%), 3 (14.3%), 12 (57.1%), and 10 (47.6%), respectively. Various lesions, such as superficial, protruded, fold thickening, or ulcerative, were found in the stomach, whereas multiple lymphomatous polyposis (MLP) was dominant from the duodenum to the rectum. Twelve patients were treated with a hyper-CVAD/MA regimen, and they had better OS (3-year rate, 88.3% vs 46.4%, P < 0.01) and better EFS (3-year rate, 66.7% vs 33.8%, P < 0.05) than the remaining 23 patients who were not treated with this regimen.
conclusionMLP was a representative form of intestinal involvement, whereas a variety of lesions were found in the stomach. The hyper-CVAD/MA regimen may improve survival in these patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.